Phase 2 5-Day Preoperative Radiation for Soft Tissue Sarcoma
The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk or retroperitoneum. This is in contrast to standard preoperative radiation, which is given over 25 days.
• Histologically confirmed soft tissue sarcoma of the extremity, trunk or retroperitoneum.
• Has been offered preoperative radiation and surgery as part of standard-of-care treatment
• Age ≥ 18
• KPS ≥ 70 or ECOG 0 to 2
• Life expectancy ≥ 6 months
• If a woman is of childbearing potential, a negative serum or urine pregnancy test must be documented.
• Ability to understand and the willingness to personally sign the written IRB approved informed consent document.